Nothing Special   »   [go: up one dir, main page]

CH541969A - Procédé de fabrication d'une préparation injectable à base de sels d'antibiotiques - Google Patents

Procédé de fabrication d'une préparation injectable à base de sels d'antibiotiques

Info

Publication number
CH541969A
CH541969A CH163972A CH163972A CH541969A CH 541969 A CH541969 A CH 541969A CH 163972 A CH163972 A CH 163972A CH 163972 A CH163972 A CH 163972A CH 541969 A CH541969 A CH 541969A
Authority
CH
Switzerland
Prior art keywords
manufacturing
injectable preparation
preparation based
antibiotic salts
antibiotic
Prior art date
Application number
CH163972A
Other languages
English (en)
Inventor
Dursch Friedrich
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of CH541969A publication Critical patent/CH541969A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CH163972A 1971-02-05 1972-02-04 Procédé de fabrication d'une préparation injectable à base de sels d'antibiotiques CH541969A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11310571A 1971-02-05 1971-02-05
US05/190,325 US3940483A (en) 1971-02-05 1971-10-18 Antibiotic compositions and method

Publications (1)

Publication Number Publication Date
CH541969A true CH541969A (fr) 1973-09-30

Family

ID=26810709

Family Applications (1)

Application Number Title Priority Date Filing Date
CH163972A CH541969A (fr) 1971-02-05 1972-02-04 Procédé de fabrication d'une préparation injectable à base de sels d'antibiotiques

Country Status (9)

Country Link
US (1) US3940483A (fr)
AU (1) AU463408B2 (fr)
BE (1) BE778999A (fr)
CA (1) CA982943A (fr)
CH (1) CH541969A (fr)
DE (1) DE2205272A1 (fr)
ES (1) ES399488A1 (fr)
FR (1) FR2124499B1 (fr)
PH (1) PH11211A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001409A (en) * 1975-05-23 1977-01-04 Bristol-Myers Company Injectable formulations of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
US4235900A (en) * 1978-11-15 1980-11-25 E. R. Squibb & Sons, Inc. Cephradine compositions
FR2445833A1 (fr) * 1979-01-04 1980-08-01 Chimie Biolog Nouveaux sels d'antibiotiques amines a cycle beta lactame
IT1124610B (it) * 1979-10-18 1986-05-07 Zambo Spa Mono(2-ammonio-2-idrossimetil-1,3-propandiolo) (2r-cis)-(o-metilossiranil)fosfonato
ES8502863A1 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
WO1988009173A1 (fr) * 1987-05-27 1988-12-01 Akzo N.V. COMPOSITiONS ANTIBIOTIQUES SECHES ET RAPIDEMENT SOLUBLES DE beta-LACTAM
IE61679B1 (en) * 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
EP0381915B1 (fr) * 1989-02-06 1995-04-12 Purzer Pharmaceutical Co., Ltd. Procédé de préparation de sels de métaux alcalins de dérivés de l'acide 7-aminocéphalo-sporanique.
IL93618A0 (en) * 1989-03-06 1990-12-23 Lilly Co Eli Improved diluent formulation for daptomycin
US5721229A (en) * 1995-12-26 1998-02-24 Veterinary Pharmacy Corporation Soluble forms of cephalosporins and treatment of animals
US6225304B1 (en) 1999-02-17 2001-05-01 Pharmaceutical Solutions, Inc. Soluble forms of amoxicillin and treatment of animals
US6669929B1 (en) 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB895027A (en) * 1959-08-03 1962-04-26 Bristol Myers Co Therapeutic tetracycline compositions
US3136691A (en) * 1962-03-05 1964-06-09 Astra Pharma Prod Aqueous solution of local anesthetic maintained under pressure
GB1195203A (en) * 1966-06-24 1970-06-17 Glaxo Lab Ltd Cephalosporins
US3485819A (en) * 1968-07-02 1969-12-23 Squibb & Sons Inc Alpha-amino-cyclohexadienylalkylene-penicillins and cephalosporins

Also Published As

Publication number Publication date
ES399488A1 (es) 1977-05-16
US3940483A (en) 1976-02-24
PH11211A (en) 1977-10-28
BE778999A (fr) 1972-08-04
FR2124499B1 (fr) 1975-10-10
AU3867572A (en) 1973-08-09
AU463408B2 (en) 1975-07-09
CA982943A (en) 1976-02-03
FR2124499A1 (fr) 1972-09-22
DE2205272A1 (fr) 1972-08-10

Similar Documents

Publication Publication Date Title
OA03930A (fr) Procédé de préparation d'azapurinones.
OA05107A (fr) Procédé de préparation d'une composition antiparasite à base de 5-propylthio-2-benzimidazolecarrbamate de méthyl.
CH541969A (fr) Procédé de fabrication d'une préparation injectable à base de sels d'antibiotiques
CH531471A (fr) Procédé de fabrication d'un béton
CH525624A (fr) Procédé de fabrication d'une composition aromatisante
CH534188A (fr) Procédé de préparation d'une composition à base de polyamides
OA04087A (fr) Procédé de préparation de nouveaux dérivés à substitution basique de benzylphtalazone et de leurs sels.
CH538474A (fr) Procédé de préparation de nouvelles phényl-2-pyrrolidinones substituées
OA04093A (fr) Procédé de préparation d'aryl-guanidines ortho-disubstituées.
BE767030A (fr) Procede de fabrication d'aiguilles monocristallines ou whiskers
CH527836A (fr) Procédé de préparation d'un dérivé de la thiazolidine
CH532567A (fr) Procédé de préparation d'Halogénures de Retinyle
OA03864A (fr) Procédé de préparation d'un médicament à base de P-chlophenoxyisobutyrate de pyridoxine.
BE792733A (fr) Procédé de préparation de polyesters
CH535830A (fr) Procédé de préparation d'antibiotiques
CH508001A (fr) Procédé de fabrication de produits résineux à base de résines polyépoxydes
CH523226A (fr) Procédé de préparation d'a-halogénophénylacétamides
CH529781A (fr) Procédé de préparation de nouvelles quinazolines
CH489557A (fr) Procédé de préparation d'une composition réticulable à base de silicone
CH538467A (fr) Procédé de préparation d'oxyde d'éthylène
CH492017A (fr) Procédé de préparation d'un nouvel antibiotique
CH522590A (fr) Procédé de préparation d'adamantylaminotétrahydronaphtyloxypropanols
CH517765A (fr) Procédé de préparation d'ortho-sulfobenzimides
CH539078A (fr) Procédé de préparation d'une a-phosphonoacétylcéphalosporin
CH534154A (fr) Procédé de préparation d'un 3-aryloxy-8-carbamoylnortropane

Legal Events

Date Code Title Description
PL Patent ceased